Insurer drug reclassification leads to price spike for patients
Health insurers are shifting expensive drugs into "tier 4" classification, resulting in a price spike for some patients, according to ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.